Table 2. Age-standardized prevalence rate of representative skin cancers.
| Variable | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 |
|---|---|---|---|---|---|---|---|---|---|
| Actinic keratosis | 7.52 | 8.76 | 9.64 | 12.27 | 14.28 | 16.29 | 18.53 | 20.80 | 22.93 |
| Bowen’s disease | 2.47 | 2.27 | 2.66 | 2.48 | 2.55 | 2.76 | 2.98 | 3.11 | 3.67 |
| Non-melanoma skin cancer | 9.15 | 10.33 | 11.11 | 12.54 | 13.68 | 14.70 | 16.13 | 17.42 | 19.20 |
| Malignant melanoma | 3.79 | 3.81 | 4.10 | 4.42 | 4.69 | 4.87 | 5.41 | 5.40 | 5.82 |
| Kaposi’s sarcoma | 0.35 | 0.34 | 0.42 | 0.46 | 0.43 | 0.46 | 0.48 | 0.50 | 0.56 |
| Connective tissue tumor | 6.09 | 6.51 | 7.08 | 7.42 | 7.80 | 8.01 | 8.50 | 8.99 | 9.51 |
| Mycosis fungoides | 0.39 | 0.49 | 0.47 | 0.51 | 0.53 | 0.55 | 0.61 | 0.64 | 0.72 |
Age-standardized prevalence rate is expressed in 100,000 person-years.